COPD Management Guidelines

Introduction to COPD

• Chronic Obstructive Pulmonary Disease (COPD) diagnosis requires objective measurement via spirometry, with severity classification based on FEV1, including categories such as mild (>80% predicted), moderate (50-80% predicted), severe (30-50% predicted), and very severe (<30% predicted) 1, 2, 3
• Post-bronchodilator FEV1/FVC <0.70 confirms persistent airflow limitation, according to the American Thoracic Society 3

Medication Management

• The European Respiratory Society recommends that patients understand how and when to take medications, and that patients using nebulizers have specific reasons for continuing nebulized treatment documented 1
• Consider roflumilast for patients with forced expiratory volume (FEV1) less than 50% predicted and chronic bronchitis, as recommended by the American Thoracic Society 3
• Consider macrolide therapy for former smokers with recurrent exacerbations, as suggested by the American Thoracic Society 3
• The European Respiratory Society recommends systemic corticosteroids, such as prednisone 30-40 mg orally daily for 10-14 days, for exacerbations of COPD 4
• Antibiotics, including amoxicillin/clavulanate or respiratory fluoroquinolones, should be considered based on local resistance patterns for exacerbations of COPD 4
• Combination therapy may be considered if Pseudomonas or Enterobacteriaceae are suspected in patients with COPD exacerbations 4
• The American Thoracic Society recommends LAMA/LABA combination therapy, such as tiotropium/olodaterol, as first-line treatment, providing superior bronchodilation, improving lung function, reducing symptoms, and decreasing exacerbation risk 3

• Treatment options for COPD include:

  Treatment	Indication
  LAMA + LABA	Patients with persistent symptoms
  Roflumilast	Patients with FEV1 < 50% predicted and chronic bronchitis
  LABA/LAMA/ICS	Patients with blood eosinophil count ≥300 cells/μL or history of asthma
  Systemic corticosteroids	Acute exacerbations
  Antibiotics	Acute exacerbations with increased sputum purulence or requiring mechanical ventilation	[3, 5, 6]

• Inhaled corticosteroids (ICS) increase the risk of pneumonia in COPD patients, and this risk should be carefully weighed against potential benefits 3, 7
• Opioids at low doses may be considered for refractory dyspnea in severe disease 3

Oxygen Therapy and Ventilation

• Long-term oxygen therapy (LTOT) is indicated for stable patients with low oxygen levels (PaO₂ ≤55 mm Hg or SaO₂ ≤88%), with or without high carbon dioxide levels, confirmed twice over 3 weeks, according to the American Thoracic Society 3
• Delivery devices for oxygen therapy include nasal cannula, venturi masks, non-rebreather masks, and reservoir cannulae in patients with COPD 4
• Monitor for CO₂ retention and acidemia when using oxygen therapy in patients with COPD 4
• Long-term oxygen therapy (LTOT) prolongs life in hypoxemic patients with COPD, as stated by the British Thoracic Society, and should be prescribed only if objectively demonstrated hypoxia (PaO2 <7.3 kPa) or high cylinder use (more than two per week) is present 1
• Consider non-invasive positive pressure ventilation (NPPV) for selected patients with pronounced daytime high carbon dioxide levels, recent hospitalization for respiratory failure, or both COPD and obstructive sleep apnea, as recommended by the American Thoracic Society 3
• Consider noninvasive positive pressure ventilation (NPPV) or invasive mechanical ventilation for patients with respiratory failure due to COPD 4

Surgical Options

• Consider bronchoscopic lung volume reduction (endobronchial valves or lung coils) for patients with heterogeneous or homogeneous emphysema and significant hyperinflation, as suggested by the American Thoracic Society 3
• Consider bullectomy for patients with a large bulla, according to the American Thoracic Society 3
• Consider lung transplantation for selected patients with very severe COPD without relevant contraindications, particularly those under 65 years of age, with very poor exercise tolerance, poor lung function (FEV1 <25% predicted), or low oxygen levels (PaO₂ <7.5 kPa) and high carbon dioxide levels (PaCO₂ >6.5 kPa), as recommended by the American Thoracic Society 3

• Surgical options for COPD include:

  Disease Type	Surgical Options
  Obstructive	Lung volume reduction surgery, bullectomy, lung transplantation
  Restrictive	Lung transplantation	[3]

• Bronchoscopic lung volume reduction (BLVR) may be considered for select patients with severe COPD who have upper-lobe predominant emphysema and persistent symptoms despite optimal medical therapy, as recommended by the American Thoracic Society 3
• Considering surgery for recurrent pneumothoraces, isolated bullous disease, or lung volume reduction in selected patients is recommended, as stated in the Thorax journal and by the British Thoracic Society 1

Pulmonary Rehabilitation and Exercise

• Pulmonary rehabilitation, including exercise training, upper extremity exercise training, and educational components, improves exercise performance, reduces breathlessness, and enhances quality of life, as suggested by the American Thoracic Society 3
• Encouraging exercise is recommended for patients with COPD, as stated by the British Thoracic Society, and pulmonary rehabilitation is the cornerstone of management for patients with chronic lung disease, improving exercise performance, reducing breathlessness, and should be implemented for all symptomatic patients, as recommended by the American College of Chest Physicians 1, 8
• The European Respiratory Society teaches proper breathing techniques, including relaxation techniques, pursed-lip breathing, and control of breathing patterns to avoid rapid, shallow breaths, and emphasizes the importance of regular exercise, such as walking, stair-climbing, treadmill, or cycling exercises, which can be successfully performed at home 5
• The European Respiratory Society notes that the benefits of exercise disappear if it is discontinued 5

Symptom Recognition and Treatment

• The European Respiratory Society provides clear instructions on actions to take when symptoms worsen, including when to contact the primary care physician and when to go to the Emergency Department, and explains the importance of prompt treatment with antibiotics and/or corticosteroids 5

Nutrition and Daily Living

• The European Respiratory Society recommends nutritional interventions aimed at achieving ideal body weight and advises against high-carbohydrate diets and extremely high caloric intake to reduce the risk of excess carbon dioxide production 5

Palliative Care and Advance Care Planning

• Palliative approaches should focus on relief of dyspnea, pain, anxiety, depression, fatigue, and nutritional support for malnourished patients, according to the American Thoracic Society 3
• Assessing and treating depression is essential for patients with COPD, as stated by the British Thoracic Society, and focus on relief of dyspnea, pain, anxiety, depression, fatigue, and poor nutrition is essential for comprehensive patient care, as recommended by the American College of Chest Physicians 1, 3
• Advance care planning should discuss possible scenarios while patients are in a stable state, inform patients about decisions regarding intensive care, and reduce anxiety and avoid unwanted invasive therapies, as recommended by the American Thoracic Society 3
• Advance care planning can reduce anxiety and avoid unwanted invasive therapies, and should include discussions with patients and families, in line with guidelines from the American Academy of Hospice and Palliative Medicine 3

Prevention and Vaccinations

• Annual influenza vaccination and pneumococcal vaccinations (PCV13 and PPSV23) are recommended for all COPD patients, particularly those over 65 years and younger patients with significant comorbidities, as suggested by the American Thoracic Society 3
• Annual influenza vaccination is recommended for all COPD patients, according to the British Thoracic Society and the Centers for Disease Control and Prevention 1
• Pneumococcal vaccination is recommended for patients with COPD, as recommended by the European Respiratory Society 1

Smoking Cessation

• Smoking cessation is crucial at all disease stages, as emphasized by the British Thoracic Society 1
• Participation in active smoking cessation programs leads to higher sustained quit rates, especially with nicotine replacement therapy, according to the British Thoracic Society 1

Referral to Specialist Care

• Referral to specialist care should be considered in cases of diagnostic uncertainty, rapid disease progression, severe symptoms despite optimal therapy, or consideration for advanced therapies, as suggested by the American Journal of Respiratory and Critical Care Medicine guidelines 9
• Preoperative optimization for patients with COPD is recommended, including smoking cessation at least 4-8 weeks before surgery, optimization of COPD management with bronchodilators, influenza vaccination, and assessment of cardiovascular risk with appropriate management of hypertension and hyperlipidemia, according to the European Society of Cardiology 10